Literature DB >> 28559776

Association between Serum Testosterone and PSA Levels in Middle-Aged Healthy Men from the General Population.

Saad Elzanaty1, Babak Rezanezhad2, Gert Dohle3.   

Abstract

INTRODUCTION: The aim of the present study was to evaluate the association between serum testosterone and PSA levels in middle-aged healthy men from the general population.
MATERIALS AND METHODS: Based on 119 healthy men from the general population, total testosterone and PSA levels were measured. Demographic data regarding BMI, waist-to-hip ratio, smoking, and alcohol consumption were also collected. Men were classified into two groups according to testosterone levels; hypogonadal (testosterone ≤ 12 nmol/l), and eugonadal (testosterone > 12 nmol/l).
RESULTS: The mean age of the subjects was 55 years (range 46-60 years). No significant correlation between serum testosterone and PSA levels was found (p = 0.60). PSA levels were similar when compared between hypogonadal and eugonadal men (1.4 µg/l vs. 1.4 µg/l, p = 0.90). When using a multivariate analysis model adjusted for the age of the subjects, BMI, waist-to-hip ratio, smoking, and alcohol consumption, a positive significant association between testosterone and PSA levels was found (β = 0.03, 95 % CI = 0.003-0.062, p = 0.03).
CONCLUSION: Only after adjusted multivariate analysis, our results indicated that testosterone was associated with PSA levels in middle-aged healthy men.

Entities:  

Keywords:  Eugonadal; Hypogonadal; PSA; Prostate cancer; Testosterone

Year:  2017        PMID: 28559776      PMCID: PMC5436005          DOI: 10.1159/000447149

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  20 in total

1.  Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.

Authors:  Ahmad Haider; Michael Zitzmann; Gheorghe Doros; Hendrik Isbarn; Peter Hammerer; Aksam Yassin
Journal:  J Urol       Date:  2014-06-26       Impact factor: 7.450

2.  Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene.

Authors:  P H Riegman; R J Vlietstra; J A van der Korput; J C Romijn; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

3.  Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.

Authors:  Jennifer A Beaulac; Richard N Fry; Jay Onysko
Journal:  Can J Public Health       Date:  2006 May-Jun

4.  Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.

Authors:  Jean-Pierre Raynaud; Jean Gardette; Jacques Rollet; Jean-Jacques Legros
Journal:  BJU Int       Date:  2013-01-07       Impact factor: 5.588

5.  Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.

Authors:  A T Guay; J B Perez; W A Fitaihi; M Vereb
Journal:  Endocr Pract       Date:  2000 Mar-Apr       Impact factor: 3.443

6.  Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

Authors:  W J Catalona; P C Southwick; K M Slawin; A W Partin; M K Brawer; R C Flanigan; A Patel; J P Richie; P C Walsh; P T Scardino; P H Lange; G H Gasior; K G Loveland; K R Bray
Journal:  Urology       Date:  2000-08-01       Impact factor: 2.649

7.  Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Authors:  Sarah B Peskoe; Corinne E Joshu; Sabine Rohrmann; Katherine A McGlynn; Sarah J Nyante; Gary Bradwin; Adrian S Dobs; Norma Kanarek; William G Nelson; Elizabeth A Platz
Journal:  Prostate       Date:  2015-04-28       Impact factor: 4.104

8.  Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.

Authors:  J Kokontis; K Takakura; N Hay; S Liao
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

9.  The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction.

Authors:  Giovanni Corona; Valentina Boddi; Francesco Lotti; Mauro Gacci; Marco Carini; Giulia De Vita; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  J Sex Med       Date:  2009-11-13       Impact factor: 3.802

10.  Is there an association between serum prostate-specific antigen values and serum testosterone levels in healthy men?

Authors:  Mahmoud Mustafa; Rahim Horuz; Metin Celik; Akif Kucukcan
Journal:  Korean J Urol       Date:  2014-07-11
View more
  2 in total

1.  Association Between Serum Testosterone and Serum PSA Among Men With and Without Partial Androgen Deficiency.

Authors:  A Shukla; B Sharda; S Sharma; S Bhardwaj; U Kailash; R Kalani; L Satyanarayana; A Shrivastava
Journal:  Indian J Clin Biochem       Date:  2018-07-31

2.  Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer.

Authors:  S Pasetto; H Enderling; R A Gatenby; R Brady-Nicholls
Journal:  Bull Math Biol       Date:  2021-11-19       Impact factor: 1.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.